New Report Just Published: World Multiple Myeloma Therapeutics Market Report
...FDA Grants Approval for Use of VELCADE(R) for Patients with Mantle Cell Lymphoma II-44 4. Recent Industry Activity II-45 CytRx to Acquire innovive II-45 Launch of Epoetin alfa Hexal II-45 PDL and Bristol-Myers Signs Agreement II-45 MNKD and LLS Conclude Joint Research Agreement II-45 ...Innovive Pharmaceuticals Announces Preclinical Data from INNO-206 Oncology Program
... NEW YORK--(BUSINESS WIRE)--Apr 18, 2007 - innovive Pharmaceuticals, Inc. (OTCBB:IVPH) announced data ...nts with sarcoma, breast and lung cancers. About innovive Pharmaceuticals innovive Pharmaceuticals, Inc. acquires, develops and comme...YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS
...ofessor of Cell Biology and Adjunct Professor of Medicine at The University of Texas M. D. Anderson Cancer Center since 1992. He is also a Director of innovive Pharmaceuticals, a New York-based oncology company. Dr. Francois Thomas, a board certified medical oncologist, is a member of the Board of Directors ...